Results: One of the CML-iPSCs, compared to its non-mutagenized counterpart, generated myeloid blasts after hematopoietic differentiation, exhibiting monoblastic patterns and expression of cMPO, CD45, CD34, CD33, and CD13. The gene discussed is CD33; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.